Eloïse Laouenan/LinkedIn
Aug 10, 2026, 14:38
Eloïse Laouenan: Closing ISTH 2026 with Two Outstanding Research Presentations
Eloïse Laouenan, PhD student in Life and Health Sciences at INSERM, midwife at CHU Brest, shared a post on LinkedIn:
”Two excellent talks to conclude our lab’s participation in ISTH 2026 congress : Pr. Francis COUTURAUD presented a new score to evaluate the risk of members family of index cases with VTE and Dr. Jamal Elhasnaoui presented the in vitro feasibility of a fluorescent anti-D-dimer antibody for thrombus targeting.
A huge congratulations to my colleague Dr. Jamal Elhasnaoui, post-doctoral researcher for his first participation in the ISTH congress.
Bravo Jamal We are proud of you !!!”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis
-
Nov 14, 2026, 13:45César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026
-
Nov 14, 2026, 13:41Hussein Abdelwahab: FDA Approves Asundexian as the First Factor XIa Inhibitor for Stroke Prevention
-
Nov 14, 2026, 13:31John Augoustides: Practical Anticoagulation Strategies for Cardiopulmonary Bypass in Patients with HIT
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment
-
Nov 14, 2026, 12:3210 Posts Not to Miss This Week
-
Nov 14, 2026, 11:28Kalyan Roy: A New Era in Thalassemia Treatment – FDA Approves Mitapivat